Paper109196
Variable oral absorption of hexamethylmelamine in man.
D'Incalci M and 4 others. Cancer Treat Rep, 1978. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Variable oral absorption of hexamethylmelamine in man. Papers, record 109196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/109196
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Altretamine | Major topic |
| Triazines | Major topic |
| Absorption | |
| Administration, Oral | |
| Adult | |
| Aged | |
| Female | |
| Half-Life | |
| Humans | |
| Middle Aged | |
| Ovarian Neoplasms |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9387041 | Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline). | Invest New Drugs | 1997 | https://conductscience.org/library/papers/9387041 | PubMed |
| 8174199 | Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further research. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8174199 | PubMed |
| 7656502 | Clinical pharmacokinetics of altretamine. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7656502 | PubMed |
| 7641606 | Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy. | Drugs | 1995 | https://conductscience.org/library/papers/7641606 | PubMed |
| 6994913 | The practical benefits of pharmacokinetics in the use of antineoplastic agents. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6994913 | PubMed |
| 6808457 | Hexamethylmelamine and hexamethylmelamine hydrochloride. | Pharm Weekbl Sci | 1982 | https://conductscience.org/library/papers/6808457 | PubMed |
| 6770884 | Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6770884 | PubMed |
| 6432969 | Human central nervous system pharmacology of pentamethylmelamine and its metabolites. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6432969 | PubMed |
| 6411375 | Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6411375 | PubMed |
| 6409137 | Clinical correlates of in vitro drug sensitivities of ovarian cancer cells. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6409137 | PubMed |
| 6401427 | Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6401427 | PubMed |
| 3888428 | Anticancer drug pharmacodynamics. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3888428 | PubMed |
| 3552281 | N-methyl antitumour agents. A distinct class of anticancer drugs? | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3552281 | PubMed |
| 3315280 | Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3315280 | PubMed |
| 3311530 | Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311530 | PubMed |
| 3117395 | Metabolism of hexamethylmelamine in mice. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3117395 | PubMed |
| 3098444 | Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenografts. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3098444 | PubMed |
| 2515524 | The bioavailability of three altretamine formulations. | Pharm Weekbl Sci | 1989 | https://conductscience.org/library/papers/2515524 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/109196
GET https://conductscience.org/api/papers/v1/109196/authors